![]() “Brand inflation is really problematic for both patients and payers,” he says. ![]() ![]() And while generics may account for 80 percent of prescription drug use in the US, he points out that brands account for 70 percent of cost. That piece of the puzzle is handled internally.Īnd from where he sits, Miller sees that brand prices are up about 80 percent over the last five years, while prices for generic medicines have fallen about 50 percent. Most importantly, patients whose plans enrolled in the SaveOnSP program pay nothing out of pocket for included medications, even after the manufacturers’ copay. But the move reflects increasing determination by payers to blunt the cost of prescription medicines, although Miller maintains the outside experts on the Pharmacy & Therapeutics committee are not allowed to consider cost. In 2020, plans that participated in these copay assistance solutions experienced a specialty trend of -7.2, while nonparticipating plans experienced an 8.7 specialty trend. Your prescription drug benefit program, administered by FutureScripts, an independent company, provides many advantages to help you easily and safely. For what a spokesman calls “rare instances,” the PBM has a standard exception process that physicians may pursue to have an off-formulary, medically necessary drug covered for patients.Īnd drugmakers, no doubt, will chafe as co-pay cards, which have been successful tools for holding on to market share, come under siege. ![]() Of course, this may cause difficulty for some people who discover that the covered medicines do not work, but another alternative is no longer an option. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |